Work

Abstract LB469: Pharmacokinetics of the EP4 antagonist HTL0039732, a CRUK first-in-human phase I trial in patients with advanced solid tumours

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-lb469

Authors: Dan Astley, Shelby Barnett, Bristi Basu, Debashis Sarker, Natalie Cook, Stefan N. Symeonides, Svatopluk Svetlik, Derrick Spencer-Briggs, Graeme Scarfe, Nigel Swain, Gareth J. Veal

Institutions: Newcastle University, University of Cambridge, Guy's Hospital, King's College London, The Christie Hospital, The Christie NHS Foundation Trust, Edinburgh Cancer Research, University of Edinburgh, Cancer Research UK

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154782740

Cites:

Cited by:

Related to: